Estimating the effect of zidovudine on Kaposi's sarcoma from observational data using a rank preserving structural failure-time model

Statistics in Medicine

Volumn 17, Issue 10, 1998, Pages 1073-1102

  Joffe, Marshall M ^a   Hoover, Donald R ^b   Jacobson, Lisa P ^b   Kingsley, Lawrence ^c   Chmiel, Joan S ^d   Visscher, Barbara R ^e   Robins, James M ^f  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

^c UNIVERSITY OF PITTSBURGH GRADUATE SCHOOL OF PUBLIC HEALTH   (United States)

^d NORTHWESTERN UNIVERSITY   (United States)

^e UNIVERSITY OF CALIFORNIA   (United States)

^f HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ZIDOVUDINE;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ARTICLE; CLINICAL TRIAL; DATA ANALYSIS; HOMOSEXUALITY; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; KAPOSI SARCOMA; MEDICAL RESEARCH; OBSERVATION; RANDOMIZED CONTROLLED TRIAL; STATISTICAL MODEL; TIME; TREATMENT FAILURE; TREATMENT OUTCOME;

ACQUIRED IMMUNODEFICIENCY SYNDROME; ANTI-HIV AGENTS; BISEXUALITY; COHORT STUDIES; HOMOSEXUALITY, MALE; HUMANS; MALE; MODELS, STATISTICAL; REGRESSION ANALYSIS; RISK; SARCOMA, KAPOSI; SKIN NEOPLASMS; TREATMENT FAILURE; TREATMENT OUTCOME; ZIDOVUDINE;

EID: 0031953986     PISSN: 02776715     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0258(19980530)17:10<1073::AID-SIM789>3.0.CO;2-P     Document Type: Article

References (73)

1. Robins, J. 'Estimation of the time-dependent accelerated failure time model in the presence of confounding factors', Biometrika, 79, 321-334 (1992).
2. Robins, J. M. 'The analysis of randomized and non-randomized AIDS treatment trials using a new approach to causal inference in longitudinal studies', in Sechrest, L., Freeman, H. and Mulley, A. (eds), Health Service Research Methodology: A Focus on AIDS, NCHSR, U.S. Public Health Service, 1989, pp. 113-159.
3. Robins, J. M. 'Analytic methods for estimating HIV-treatment and cofactor effects', in Ostrow, D. G. and Kessler, R. (eds), Methodological Issues of AIDS Behavioral Research, Plenum, New York, 1993, pp. 213-287.
4. Robins, J. M., Blevins, D., Ritter, G. and Wulfsohn, M. 'G-estimation of the effect of prophylaxis therapy for pneumocystic carinii pneumonia on the survival of AIDS patients', Epidemiology, 3, 319-366 (1992).
5. Mark, S. D. and Robins, J. M. 'Estimating the causal effect of smoking cessation in the presence of confounding factors using a rank preserving structural failure time model', Statistics in Medicine, 12, 1605-1628 (1993).
6. Robins, J. M. and Greenland, S. 'Adjusting for differential rates of prophylaxis therapy for PCP in high-versus low-dose AZT treatment arms in an AIDS randomized trial', Journal of the American Statistical Association, 89, 737-749 (1994).
7. Jacobson, L. P., Munoz, A., Fox, R., Phair, J. P., Dudley, J., Obrams, G. I., Kingsley, L. A., Polk, B. F. and The Multicenter AIDS Cohort Study, 'Incidence of Kaposi's sarcoma in a cohort of homosexual men infected with the human immunodeficiency virus type 1', Journal of Acquired Immune Deficiency Syndromes, 3, (Suppl. 1), S24-S31 (1990).
8. Kaldor, J. M., Tindall, B., Williamson, P., Elford, J. and Cooper, D. A. 'Factors associated with Kaposi's sarcoma in a cohort of homosexual and bisexual men', Journal of Acquired Immune Deficiency Syndromes, 6, 1145-1149 (1993).
9. American Foundation for AIDS Research. AIDS/HIV Treatment Directory, Vol. 6, 1993.
10. Hoover, D. R., Black, C., Jacobson, L. P., Martinez-Maza, O., Seminara, D., Saah, A., Von Roenn, J., Anderson, R. and Armenian, H. K. 'Epidemiologic analysis of Kaposi's sarcoma as an early and later AIDS outcome in homosexual men', American Journal of Epidemiology, 138, 266-278 (1993).
11. Concorde Coordinating Committeee. 'Concorde: MRC/ANRS randomised double-blind controlled trial of immediate and deferred zidovudine in symptom-free HIV infection', Lancet, 343, 871-881 (1994).
12. Cooper, D. A., Gatell, J. M., Kroon, S., Clumeck, N., Millard, J., Goebel, F. -D., Bruun, J. N., Stingl, G., Melville, R. L., Gonzalez-Lahoz, J., Stevens, J. W., Fiddian, A. P. and The European-Australian Collaborative Group, 'Zidovudine in persons with asymptomatic HIV infection and CD4 + cell counts greater than 400 per cubic millimeter', New England Journal of Medicine, 329, 297-303 (1993).
13. Fischl, M. A., Richman, D. D., Grieco, M. H., Gottlieb, M. S., Volberding, P. A., Laskin, O. L., Leedom, J. M., Groopman, J. E., Mildvan, D., Schooley, R. T., Jackson, G. G., Durack, D. T., King, D. and The AZT Collaborative Working Group, 'The efficacy of azidothymidine (AZT) in the treatment of patients with AIDS and AIDS-related complex: a double-blind, placebo-controlled trial', New England Journal of Medicine, 317, 185-191 (1987).
14. Fischl, M. A., Parker, C. B., Pettinelli, C., Wulfsohn, M., Hirsch, M. S., Collier, A. C., Antoniskis, D., Ho, M., Richman, D. D., Fuchs, E., Merigan, T. C., Reichman, R. C., Gold, J., Steigbigel, N., Leoung, G. S., Rasheed, S., Tsiatis, A. and The AIDS Clinical Trials Group, 'A randomized controlled trial of a reduced daily dose of zidovudine in patients with the acquired immunodeficiency syndrome', New England Journal of Medicine, 323, 1009-1014 (1990).
15. Fischl, M. A., Richman, D. D., Hansen, N., Collier, A. C., Carey, J. T., Para, M. F., Hardy, W. D., Dolin, R., Powderly, W. G., Allan, J. D., Wong, B., Merigan, T. C., McAuliffe, V. J., Hyslop, N. E., Rhame, F. S., Balfour, H. H., Spector, S. A., Volberding, P., Pettinelli, C., Anderson, J. and the AIDS Clinical Trials Group. 'The safety and efficacy of zidovudine (AZT) in the treatment of subjects with mildly symptomatic human immunodeficiency virus type 1 (HIV) infection: a double-blind, placebo-controlled trial', Annals of Internal Medicine, 112, 727-737 (1990).
16. Fischl, M. A., Richman, D. D., Causey, D. M., Grieco, M. H., Bryson, Y., Mildvan, D., Laskin, O. L., Groopman, J. E., Volberding, P. A., Schooley, R. T., Jackson, G. G., Durack, D. T., Andrews, J. C., Nusinoff-Lehrman, S., Barry, D. W. and The AZT Collaborative Working Group. 'Prolonged zidovudine therapy in patients with AIDS and advanced AIDS-related complex', Journal of the American Medical Association, 262, 2405-2410 (1989).
17. Hamilton, J. D., Hartigan, P. M., Simberkoff, M. S., Day, P. L., Diamond, G. R., Dickinson, G. M., Drusano, G. L., Egorin, M. J., George, W. L., Gordin, F. M., Hawkes, C. A., Jensen, P. C., Klimas, N. G., Labriola, A. M., Lahart, C. J., O'Brien, W. A., Oster, C. N., Weinhold, K. J., Wray, N. P., Zolla-Pazner, S. B. and The Veterans Affairs Cooperative Study Group on AIDS Treatment. 'A controlled trial of early versus late treatment with zidovudine in symptomatic human immunodeficiency virus infection', New England Journal of Medicine, 326, 437-443 (1992).
18. Mulder, J. W., Cooper, D. A., Mathiesen, L., Sandstrom, E., Clumeck, N., Gatell, J. M., French, M., Donovan, B., Gray, F., Yeo, J. M., Lange, J. M. A. and The European-Australian Collaborative Group. 'Zidovudine twice daily in asymptomatic subjects with HIV infection and a high risk of progression to AIDS: a randomized, double-blind placebo-controlled study', AIDS, 8, 313-321 (1994).
19. Nordic Medical Research Councils' HIV Therapy Group. 'Double blind dose-response study of zidovudine in AIDS and advanced HIV infection', British Medical Journal, 304, 13-17 (1992).
20. Richman, D. D., Fischl, M. A., Grieco, M. H., Gottlieb, M. S., Volberding, P. A., Laskin, O. L., Leedom, J. M., Groopman, J. E., Mildvan, D., Hirsch, M. S., Jackson, G. G., Durack, D. T., Nusinoff-Lehrman, S. and The AZT Collaborative Working Group, 'The toxicity of azidothymidine (AZT) in the treatment of patients with AIDS and AIDS-related complex: a double-blind, placebo-controlled trial', New England Journal of Medicine, 317, 192-197 (1987).
21. Volberding, P. A., Lagakos, S. W., Koch, M. A., Pettinelli, C., Myers, M. W., Booth, D. K., Balfour, H. H. Reichman, R. C. Bartlett, J. A., Hirsch, M. S., Murphy, R. L., Hardy, W. D., Soeiro, R., Fischl, M. A., Bartlett, J. G., Merigan, T. C., Hyslop, N. E., Richman, D. D., Valentine, F. T., Corey, L. and The AIDS Clinical Trials Group of the National Institute of Allergy and Infectious Diseases. 'Zidovudine in asymptomatic human immunodeficiency virus infection: a controlled trial in persons with fewer than 500 CD4-positive cells per cubic millimeter', New England Journal of Medicine, 322, 941-949 (1990).
22. Buira, E., Gatell, J. M., Miro, J. M., Batalla, J., Zamora, L., Mallolas, J., Aznar, E., Soriano, E. and San Miguel, J. G. 'Influence of treatment with zidovudine (ZDV) on the long-term survival of AIDS patients', Journal of Acquired Immune Deficiency Syndromes, 5, 737-742 (1992).
23. Creagh-Kirk, T., Doi, P., Andrews, E., Nusinoff-Lehrman, S., Tilson, H., Hoth, D. and Barry, D. W. 'Survival experience among patients with AIDS receiving zidovudine', Journal of the American Medical Association, 260, 3009-3015 (1988).
24. Graham, N. M. H., Zeger, S. L., Park, L. P., Phair, J. P., Detels, R., Vermund, S. H., Ho, M., Saah, A. J. and The Multicenter AIDS Cohort Study, 'Effect of zidovudine and Pneumocystis carinii pneumonia prophylaxis on progression of HIV-1 infection to AIDS', Lancet, 338, 265-269 (1991).
25. Graham, N. M. H., Zeger, S. L., Park, L. P., Vermund, S. H., Detels, R., Rinaldo, C. R. and Phair, J. P. 'The effects on survival of early treatment of human immunodeficiency virus infection', New England Journal of Medicine, 326, 1037-1042 (1992).
26. Moore, R. D., Hidalgo, J., Sugland, B. W. and Chaisson, R. E. 'Zidovudine and the natural history of the acquired immunodeficiency syndrome', New England Journal of Medicine, 324, 1412-1416 (1991).
27. Vella, S., Giuliano, M., Pezzotti, P., Agresti, M. G., Tomino, C., Florida, M., Greco, D., Moroni, M., Visco, G., Milazzo, F., Giannelli, F., Angarano, G., Ortona, L., Zanussi, C. and The Zidovudine Evaluation Group. 'Survival of zidovudine-treated patients with AIDS compared with that of contemporary untreated patients', Journal of the American Medical Association, 267, 1232-1236 (1992).
28. Saah, A. J., Hoover, D. R., He, Y., Kingsley, L. A., Phair, J. P. and The Multicenter AIDS Cohort Study. 'Factors influencing survival after AIDS: report from the Multicenter AIDS Cohort Study (MACS)', Journal of Acquired Immune Deficiency Syndromes, 7, 287-295 (1994).
29. Gelber, R. D., Lenderking, W. R., Cotton, D. J., Cole, B. F., Fischl, M. A., Goldhirsch, A., Testa, M. A. and The AIDS Clinical Trials Group. 'Quality-of-life in a clinical trial of zidovudine therapy in patients with mildly symptomatic HIV infection', Annals of Internal Medicine, 116, 961-966 (1992).
30. Lenderking, W. R., Gelber, R. D., Cotton, D. J., Cole, B. F., Goldhirsch, A., Volberding, P. A. and Testa, M. A. 'Evaluation of the quality of life associated with zidovudine treatment in asymptomatic human immunodeficiency virus infection', New England Journal of Medicine, 330, 738-743 (1994).
31. Wu, A. W., Mathews, W. C., Brysk, L. T., Atkinson, J. H., Grant, I., Abramson, I., Kennedy, C. J., McCutchan, J. A., Spector, S. A. and Richman, D. D. 'Quality of life in a placebo-controlled trial of zidovudine in patients with AIDS and AIDS-related complex', Journal of Acquired Immune Deficiency Syndromes, 3, 683-690 (1990).
32. Armenian, H. K., Hoover, D. R., Rubb, S., Metz, S., Kaslow, R., Visscher, B., Chmiel, J., Kingsley, L. and Saah, A. 'Composite risk score for Kaposi's sarcoma based on a case-control and longitudinal study in the Multicenter AIDS Cohort Study (MACS) population', American Journal of Epidemiology, 138, 256-265 (1993).
33. Kaslow, R. A., Ostrow, D. G., Detels, R., Phair, J. P., Polk, B. F., Rinaldo, C. R. and The Multicenter AIDS Cohort Study. 'The Multicenter AIDS Cohort Study: rationale, organization, and selected characteristics of the participants', American Journal of Epidemiology, 126, 310-318 (1987).
34. Graham, N. M. H., Zeger, S. L., Kuo, V., Jacobson, L. P., Vermund, S. H., Phair, J. P., Detels, R., Rinaldo, C. R., Saah, A. J. and The Multicenter AIDS Cohort Study. 'Zidovudine use in AIDS-free HIV-1-seropositive homosexual men in the Multicenter AIDS Cohort Study (MACS), 1987-1989', Journal of Acquired Immune Deficiency Syndromes, 4, 267-276 (1991).
35. Robins, J. 'A new approach to causal inference in mortality studies with a sustained exposure period-application to control of the healthy worker survivor effect', Mathematical Modelling, 7, 1393-1512 (1986).
36. Robins, J. 'A graphical approach to the identification and estimation of causal parameters in mortality studies with sustained exposure periods', Journal of Chronic Diseases, 40, 139S-161S (1987).
37. Robins, J. 'The control of confounding by intermediate variables', Statistics in Medicine, 8, 679-701 (1989).
38. Greenland, S. 'Modeling and variable selection in epidemiologic analysis', American Journal of Public Health, 79, 340-349 (1989).
39. Cox, D. R. and Oakes, D. Analysis of Survival Data, Chapman and Hall, London, 1984.
40. Lipsky, J. J. 'Concorde lands', Lancet, 343, 866-867 (1994).
41. Volberding, P. A., Lagakos, S. W., Grimes, J. M., Stein, D. S., Balfour, H. H., Reichman, R. C., Bartlett, J. A., Hirsch, M. S., Phair, J. P., Mitsuyasu, R. T., Fischl, M. A., Soeiro, R. and the AIDS Clinical Trials Group of the National Institute of Allergy and Infectious Diseases. 'The duration of zidovudine benefit in persons with asymptomatic HIV infection: prolonged evaluation of protocol 019 of the AIDS Clinical Trials Group', Journal of the American Medical Association, 272, 437-442 (1994).
42. Robins, J. M. 'Structural nested failure time models', in Keiding, N. and Andersen, P. K. (eds), The Encyclopedia of Biostatistics, Vol. Survival Analysis, Wiley, Chichester, 1998.
43. Robins, J. M. 'Errata for "A new approach to causal inference in mortality studies with a sustained exposure period-application to control of the healthy worker survivor effect"', Computers and Mathematics with Applications, 14, 917-921 (1987).
44. Robins, J. 'Addendum to "A new approach to causal inference in mortality studies with a sustained exposure period-application to control of the healthy worker survivor effect"', Computers and Mathematics with Applications, 14, 923-945 (1987).
45. Rosenbaum, P. R. and Rubin, D. B. 'The central role of the propensity score in observational studies for causal effects', Biometrika, 70, 41-55 (1983).
46. Robins, J. M. and Tsiatis, A. A. 'Semiparametric estimation of an accelerated failure time model with time-dependent covariates', Biometrika, 79, 311-319 (1992).
47. Cox, D. R. 'Regression models and life-tables (with discussion)', Journal of the Royal Statistical Society, Series B, 34, 187-220 (1972).
48. Oakes, D. 'A note on the Kaplan-Meier estimator', American Statistician, 47, 39-40 (1993).
49. Kaplan, E. L. and Meier, P. 'Nonparametric estimation from incomplete observations', Journal of the American Statistical Association, 53, 457-481 (1958).
50. Berkson, J. and Gage, R. P. 'Survival curve for cancer patients following treatment', Journal of the American Statistical Association, 47, 501-515 (1952).
51. Pearl, J. 'Causal diagrams for empirical research', Biometrika, 83, 669-690 (1995).
52. Arjas, E. and Eerola, M. 'On predictive causality in longitudinal studies', Journal of Statistical Planning and Inference, 34, 361-386 (1993).
53. Rosenbaum, P. R. 'Conditional permutation tests and the propensity score in observational studies', Journal of the American Statistical Association, 79, 565-574 (1984).
54. Rosenbaum, P. R. 'The consequences of adjustment for a concomitant variable that has been affected by the treatment', Journal of the Royal Statistical Society, Series A, 147, 656-666 (1984).
55. Mark, S. D. and Robins, J. M. 'A method for the analysis of randomized trials with compliance information: an application to the multiple risk factor intervention trial', Controlled Clinical Trials, 14, 79-97 (1993).
56. Kalbfleisch, J. D. and Prentice, R. L. The Statistical Analysis of Failure Time Data, Wiley, New York, 1980.
57. Rothman, K. J. Modern Epidemiology, Little, Brown and Co., Boston, 1986.
58. Greenland, S. and Neutra, R. 'Control of confounding in the assessment of medical technology', International Journal of Epidemiology, 9, 361-367 (1980).
59. Munoz, A., Schrager, L. K., Bacellar, H., Speizer, I., Vermund, S. H., Detels, R., Saah, A. J., Kingsley, L. A., Seminara, D. and Phair, J. P. 'Trends in the incidence of outcomes defining acquired immunodeficiency syndrome (AIDS) in the Multicenter AIDS Cohort Study: 1985-1991', American Journal of Epidemiology, 137, 423-438 (1993).
60. Little, R. J. A. and Rubin, D. B. Statistical Analysis With Missing Data, Wiley, New York, 1987.
61. Rubin, D. B. and Schenker, N. 'Multiple imputation in health-care databases: an overview and some applications', Statistics in Medicine, 10, 585-598 (1991).
62. Rubin, D. B. Multiple Imputation for Nonresponse in Surveys, Wiley, New York, 1987.
63. Joffe, M. M. 'Estimation of the effect of a treatment on a failure-time outcome using structural nested failure-time models and G-estimation', Ph.D. dissertation, University of California, Los Angeles, 1994.
64. Robins, J. M. and Rotnitzky, A. 'Recovery of information and adjustment for dependent censoring using surrogate markers', in Jewell, N. P., Dietz, K. and Farewell, V. (eds), AIDS Epidemiology: Methodological Issues, Birkhauser, Boston, 1992, pp. 297-331.
65. White, H. 'Maximum likelihood estimation of misspecified models', Econometrica, 50, 1-25 (1982).
66. Checkoway, H., Pearce, N. E. and Crawford-Brown, D. J. Research Methods in Occupational Epidemiology, Oxford, New York, 1989.
67. Lavori, P. W., Dawson, R. and Mueller, T. B. 'Causal estimation of time-varying treatment effects in observational studies: application to depressive disorder', Statistics in Medicine, 13, 1089-1100 (1994).
68. Miettinen, O. S. 'The need for randomization in the study of intended effects', Statistics in Medicine, 2, 267-271 (1983).
69. Pocock, S. J. Clinical Trials: A Practical Approach, Wiley, Chichester, 1983.
70. Goedert, J. J., Biggar, R. J., Melbye, M., et al. 'Effect of T4 count and cofactors on the incidence of AIDS in homosexual men infected with human immunodeficiency virus', Journal of the American Medical Association, 257, 331-334 (1987).
71. Greenland, S. 'Confounding in epidemiologic studies', Biometrics, 45, 1309-1310 (1989).
72. Goetghebeur, E. J. T. and Pocock, S. J. 'Statistical issues in allowing for noncompliance and withdrawal', Drug Information Journal, 27, 837-845 (1993).
73. Newcombe, R. G. 'Explanatory and pragmatic estimates of the treatment effect when deviations from alloated treatment occur', Statistics in Medicine, 7, 1179-1186 (1988).